GeneChem Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
90
- Portfolio
-
9
- Exits
-
53
GeneChem General Information
Company Description
Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada. The firm seeks to invest in United States, Canada, and Europe-based companies operating in the drug discovery and development sector.
Business Details
Website
www.genechem.com/index.phpYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1, Westmount Square
- Suite 800
- Montreal, Quebec H3Z 2P9
- Canada
GeneChem Investments (90)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Giiant Pharma | 30-Jun-2021 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Inversago Pharma | 08-Sep-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Neurasic Therapeutics | 25-Mar-2020 | Drug Discovery | Generating Revenue | |||
| MyX Therapeutics | 09-Oct-2018 | Drug Delivery | Bankruptcy: Liquidation | |||
| Inversago Pharma | 25-Jul-2018 | Drug Discovery | Clinical Trials - Phase 2 | |||
| SemaThera | 21-Mar-2018 | Biotechnology | Pre-Clinical Trials | |||
| SpecificiT Pharma | 23-Aug-2017 | Biotechnology | Out of Business | |||
| SemaThera | 11-Jan-2017 | Biotechnology | Pre-Clinical Trials | |||
| Corbin Therapeutics | 05-Jan-2017 | Seed Round | Drug Discovery | Startup | ||
| Mperia Therapeutics | 12-Sep-2016 | Early Stage VC | Drug Discovery | Out of Business |
GeneChem Exits (53)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Inversago Pharma | 08-Sep-2023 | Merger/Acquisition | |
| Mperia Therapeutics | 31-Dec-2021 | ||
| MyX Therapeutics | 31-Dec-2021 | ||
| SpecificiT Pharma | 31-Dec-2021 | ||
| NuChem Sciences | 22-Feb-2019 | ||
| Sorbent Therapeutics | 01-Jan-2018 | ||
| Viron Therapeutics | 01-Jan-2018 | ||
| Ocera Therapeutics | 01-Dec-2017 | ||
| AmpliPhi Biosciences | 03-Feb-2017 | Secondary Transaction - Open Market | |
| Koronis Pharmaceuticals | 01-Sep-2016 | Merger/Acquisition |
GeneChem Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
GeneChem Co-Investors (10)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| 50 North Ventures | 1 |
|
|
||
| Anges Québec |
|
|
|||
| Fonds de solidarite FTQ |
|
|
|||
| Genesys Capital |
|
|
|||
| Seido Capital |
|
|
GeneChem FAQs
-
What is GeneChem?
Founded in 1997, GeneChem is a venture capital firm based in Montreal, Canada.
-
When was GeneChem founded?
GeneChem was founded in 1997.
-
Where is GeneChem headquartered?
GeneChem is headquartered in Montreal, Canada.
-
What is GeneChem's total asset value?
GeneChem has around in total assets under management.
-
How many investments has GeneChem made?
GeneChem has made 90 investments.
-
What has GeneChem invested in?
GeneChem has made numerous investments in companies like Giiant Pharma, Inversago Pharma, and Neurasic Therapeutics within the Drug Discovery industry.
-
What has GeneChem invested in recently?
GeneChem's latest investment was on 30-Jun-2021 in Giiant Pharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
